Table 4 Clinical characteristics of the SVR and non-SVR patients
|  | SVR patients (n = 23)1 | Non-SVR patients (n = 18)1 | Significance |
|---|---|---|---|
Age (year) | 52.13 ± 7.86 | 53.78 ± 7.20 | p = 0.4530 |
Gender |  |  | p = 0.7020 |
 Male | 14 | 12 |  |
 Female | 9 | 6 |  |
BMI | 23.22 ± 2.98 | 22.27 ± 2.95 | p = 0.3510 |
ALT (U/L)2 | 156.59 ± 134.65 | 80.74 ± 67.90 | p = 0.0659 |
AST (U/L)2 | 104.59 ± 97.74 | 65.27 ± 59.63 | p = 0.1180 |
PLT (×109/L)2 | 138.30 ± 57.34 | 205.94 ± 102.76 | p = 0.0551 |
AFP 2 | 2.99 ± 1.23 | 4.68 ± 2.96 | p = 0.0841 |
HCV RNA (×106 eq/mL)2 | 1.15 ± 1.60 | 8.78 ± 9.92 | p = 0.0051 |
FibroScan2 | 17.16 ± 7.98 | 13.56 ± 7.15 | p = 0.1412 |
Liver fibrosis assessed by FibroScan |  |  | p = 0.2170 |
 Non-LC | 7 | 9 |  |
 Indeterminate | 6 | 6 |  |
 LC | 10 | 3 |  |
R of LecT-Hepa | −0.60 ± 1.48 | 0.79 ± 1.54 | p = 0.0031 |
R of FIB4 | 0.38 ± 2.00 | 0.62 ± 1.76 | p = 0.5545 |
R of APRI | 0.01 ± 0.60 | 0.04 ± 0.28 | p = 0.7626 |